Media Contacts

Matt Miller
Director, Communications and Public Relations
mrmille2@uci.edu

Michelle Strombeck
Manager, Communications and Public Relations
312-498-8208
mstrombe@hs.uci.edu

Stay Connected

Antihypertensive Properties of Green and Black TEA

Apr 08, 2021 | UCI School of Medicine

Geoff Abbott, PhD, speaks on Super Human Radio about the Antihypertensive Properties of Green and Black Tea

A new study from the University of California, Irvine shows that compounds in both green and black tea relax blood vessels by activating ion channel proteins in the blood vessel wall. The discovery helps explain the antihypertensive properties of tea and could lead to the design of new blood pressure-lowering medications.
Tahseen Mozaffar, MD

Apr 06, 2021 | UCI School of Medicine

UCI awarded 5-year, $4.2M grant to study rare muscle disorder affecting aging Americans

Currently untreatable, sporadic inclusion body myositis (sIBM) causes muscle weakness and severe disability
Chika Okeke

Apr 06, 2021 | CNBC

Medical students haven’t been deterred by the stress of Covid on hospitals and staff — they are eager to help

As we head into the second year of the coronavirus pandemic, health-care workers have been applauded as heroes for fighting an unpredictable and deadly virus. It’s taken a toll on them physically and mentally, yet applications to medical schools for the 2021 academic year have surged by 18%, according to the Association of American Medical Colleges.
Picture of Francisco Gutierrez Carranza

Apr 01, 2021 | UCI Office of Inclusive Excellence

2021 Latino Excellence and Achievement Awards

Graduate Student Francisco Gutierrez Carranza and Professor Dr. José Mayorga honored at 2021 Latino Excellence and Achievement Awards Dinner.

Latino Excellence and Achievement Award

Apr 01, 2021 | UCI Office of Inclusive Excellence

UCI School of Medicine community members honored at 2021 Latino Excellence and Achievement Awards

This LEAD gala honors key leaders, graduate students, staff and faculty who support and champion student success and research excellence in the Latinx/Hispanic community at UCI and in Orange County.
Infants looking at the camera

Apr 01, 2021 | UCI School of Medicine

UCI-led team awarded $2.3 million as part of the California Initiative to Advance Precision Medicine

Precision medicine will be used to study the impacts of adverse and unpredictable experiences on children's neurodevelopment
stethescope

Mar 23, 2021 | Businesswire

Dr. Jonathan Lakey Named to Head Development Team to Further GATC Health’s Diabetes Diagnoses and Treatment Platform

GATC Health, an innovative technology company focused on whole genome testing and Predictive Multiomics™, today announced that Dr. Jonathan Lakey, co-developer of the Edmonton Protocol and world-renowned diabetes and islet transplantation expert, has joined the company’s board of advisors.
Lisa Wagar

Mar 22, 2021

Lisa Wagar: Recipient of the 2021 Michelson Philanthropies and Science prize for Immunology. The prize recognizes the immune responses to viruses and vaccines using human tonsil organoids. Her associated essay was published in Science.

Lisa Wagar: Recipient of the 2021 Michelson Philanthropies and Science prize for Immunology. The prize recognizes the immune responses to viruses and vaccines using human tonsil organoids. Her associated essay was published in Science.
Ariana Naaseh, Kaosoluchi Enendu and Alfonso Ortiz Cruz

Mar 15, 2021 | UCI News

Residents-in-waiting

We highlight three graduating medical students who have excelled despite unprecedented challenges
Structural model showing the tea flavonoid binding to the base of a voltage sensor of KCNQ5.

Mar 08, 2021 | UCI School of Medicine

New discovery explains antihypertensive properties of green and black tea

A new study from the University of California, Irvine shows that compounds in both green and black tea relax blood vessels by activating ion channel proteins in the blood vessel wall. The discovery helps explain the antihypertensive properties of tea and could lead to the design of new blood pressure-lowering medications.